AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

JAPAN…..Takeda wins Japanese OK for Adcetris

 japan  Comments Off on JAPAN…..Takeda wins Japanese OK for Adcetris
Jan 202014
 

Takeda wins Japanese OK for Adcetris

Takeda’s Adcetris (brentuximab vedotin) has been given the regulatory go-head in Japan to treat malignant lymphoma.

More specifically, the Japanese Ministry of Health, Labour and Welfare (MHLW) has issued a greenlight for its use in patients with CD30 Positive Relapsed or Refractory Hodgkin Lymphoma (HL) or Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL).

Read more at: http://www.pharmatimes.com/Article/14-01-18/Takeda_wins_Japanese_OK_for_Adcetris.aspx#ixzz2qwGAi5Qo

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: